Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB 1 receptor characterization, distribution, and G-protein activation

Author： Darmani N.A.   Sim-Selley L.J.   Martin B.R.   Janoyan J.J.   Crim J.L.   Parekh B.   Breivogel C.S.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.459, Iss.1, 2003-01, pp. : 83-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The cannabinoid CB 1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2

By Darmani N.A.  

European Journal of Pharmacology, Vol. 430, Iss. 1, 2001-10 ,pp. : 49-58

Elsevier

Access to resources Recommend Favorite

CB1 Cannabinoid Receptor Ligands

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 631-640

Bentham Science Publishers

Access to resources Recommend Favorite

Differences in G-protein activation by - and -opioid, and cannabinoid, receptors in rat striatum

By Sim L.J.   Selley D.E.   Xiao R.   Childers S.R.  

European Journal of Pharmacology, Vol. 307, Iss. 1, 1996-06 ,pp. : 97-105

Elsevier

Access to resources Recommend Favorite

Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices

By Gifford A.N.   Samiian L.   Gatley S.J.   Ashby Jr. C.R.  

European Journal of Pharmacology, Vol. 324, Iss. 2, 1997-04 ,pp. : 187-192

Elsevier

Access to resources Recommend Favorite

Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine

By Arnold J.C.   Topple A.N.   Hunt G.E.   McGregor I.S.  

European Journal of Pharmacology, Vol. 354, Iss. 1, 1998-07 ,pp. : 9-16

Elsevier

Access to resources Recommend Favorite